PSDV - pSivida Corp.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

pSivida Corp.

480 Pleasant Street
Suite B300
Watertown, MA 02472
United States

IndustryDrugs - Generic
Full Time Employees22

Key Executives

Mr. Leonard S. RossPrincipal Financial & Accounting Officer and VP of Fin.N/AN/A67
Ms. Nancy S. LurkerCEO, Pres & DirectorN/AN/A60
Mr. Marty NazzaroVP of OperationsN/AN/AN/A
Ms. Deborah A. JornExec. VP of Corp. and Commercial Devel.N/AN/A59
Dr. Dario A. Paggiarino M.D.Chief Medical OfficerN/AN/A60
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


pSivida Corp. develops sustained-release drug-delivery products for the treatment of chronic eye diseases in the United States and the United Kingdom. It offers ILUVIEN, an injectable, sustained-release micro-insert for use in treating vision impairment associated with diabetic macular edema; and Retisert for the treatment of posterior segment uveitis. The company is also developing Medidur, an injectable, sustained-release micro-insert, which is in Phase III clinical trials for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. Its pre-clinical development program focuses on developing products using its core platform technologies, Durasert and Tethadur, to deliver drugs and biologics to treat wet and dry age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. The company has strategic collaborations with Alimera Sciences, Inc.; Pfizer, Inc.; Bausch & Lomb Incorporated; and Enigma Therapeutics Limited. pSivida Corp. was founded in 1987 and is headquartered in Watertown, Massachusetts.

Corporate Governance

pSivida Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.